NCT01272739

Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of IHBG-10 on Weight Loss and Body Composition

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Avera McKennan Hospital & University Health Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight loss, and changes in body composition.

Detailed description

Subjects will be randomized to one of two groups: one group will take 500 mg of the investigational product (IHBG-10) 15 minutes prior to the three main meals of the day; the other group will take placebo 15 minutes prior to the three main meals of the day. Subjects will be on the investigational product or placebo for 12 weeks. Participation in this study involves four study visits.

Conditions

• Obesity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	IHBG-10	500 mg of IHBG-10 taken 15 minutes prior to the three main meals of the day
DIETARY_SUPPLEMENT	Placebo	Placebo taken 15 minutes prior to the three main meals of the day

Timeline

• Start date: 2011-02-01
• Primary completion: 2011-07-01
• Completion: 2011-07-01
• First posted: 2011-01-10
• Last updated: 2011-10-06

Locations

1 site across 1 country: United States